Genetic testing of embryos for the clinician
On this page you will learn
- The three kinds of preimplantation genetic testing (PGT) in plain words
- What the clinician does before, during and after a PGT cycle
- The limits of PGT-A and why it is not routine
- What the ART Act and the PCPNDT Act allow and forbid
Three kinds of PGT
PGT tests a few cells from an IVF embryo before transfer. There are three kinds, and they answer different questions:
- PGT-M (monogenic): does this embryo carry the known single-gene condition that runs in this family, such as thalassaemia?
- PGT-SR (structural rearrangement): has this embryo inherited an unbalanced form of a parent's chromosome rearrangement?
- PGT-A (aneuploidy): does this embryo have the usual number of chromosomes?
The ESHRE PGT Consortium published its good practice papers in 2020: one on organising a PGT service, one on biopsy, and one each on the testing methods.
Source: 2020, ESHRE PGT Consortium, Human Reproduction Open hoaa021 - ESHRE PGT Consortium good practice recommendations for the organisation of PGT
The clinician's part
The lab biopsies the embryo and the genetics laboratory tests it. Your part is everything around that:
- Confirm the indication: a known familial variant, a parental rearrangement, or a well-argued reason for PGT-A
- Arrange genetic counselling before the cycle, with the genetic report of the family in the file
- Plan stimulation for enough embryos, since some will be affected or not diagnosable
- Explain that embryos are usually frozen while results are awaited, and transferred later (page 54)
- After a pregnancy, discuss confirmation by prenatal diagnosis with the obstetric team
ESHRE's organisation paper sets out the counselling: the steps, the limits, the chance that no embryo is suitable for transfer, and follow-up of the pregnancy and child.
Source: 2020, ESHRE PGT Consortium, Human Reproduction Open hoaa021 - ESHRE PGT Consortium good practice recommendations for the organisation of PGT
The lab part, in one paragraph
At the blastocyst stage the embryologist removes a few cells from the outer layer, which will become the placenta, and sends them to a genetics laboratory. The inner cell mass, which forms the baby, is not touched. The embryo is usually vitrified. You do not need the biopsy technique; you need to know that the sample is small, and that a small sample can mislead.
Source: 2020, ESHRE PGT Consortium and SIG Embryology, Human Reproduction Open hoaa020 - ESHRE PGT Consortium and SIG Embryology good practice recommendations for polar body and embryo biopsy for PGT
Limits of PGT-A
PGT-A sounds like a way to pick the "right" embryo. The evidence is more modest. ESHRE does not recommend PGT-A for routine use; in recurrent implantation failure it says PGT-A can be considered.
Source: 2023, ESHRE Add-ons Working Group, Human Reproduction 38(11):2062-2104 - Good practice recommendations on add-ons in reproductive medicine
Source: 2023, ESHRE Working Group on Recurrent Implantation Failure (Cimadomo et al.), Human Reproduction Open hoad023 - ESHRE good practice recommendations on recurrent implantation failure
- Mosaicism: an embryo can contain both normal and abnormal cells; the few cells tested may not represent the whole.
- False results: a normal embryo may be labelled abnormal and never used.
- No result: some biopsies cannot be read.
- Fewer embryos: the couple may end with none to transfer.
PGT-A cannot make an embryo better. All it can do is help choose among embryos the couple already has.
The law in India
Section 25 of the ART Act says PGT shall be used to screen embryos for known, pre-existing, heritable or genetic diseases only. Read it with the current rules and National Board guidance before offering PGT for any other reason, and follow the clinic's written policy.
Source: 18 Dec 2021, Government of India (Act No. 42 of 2021) - The Assisted Reproductive Technology (Regulation) Act, 2021 (section 25)
Section 26 of the same Act, read with the PCPNDT Act, forbids offering a child of a chosen sex and any act to identify the sex of an embryo, except to diagnose, prevent or treat a sex-linked disease. No report, conversation or note may reveal the sex of an embryo for any other reason. Advertising such a service is itself an offence.
Source: 18 Dec 2021, Government of India (Act No. 42 of 2021) - The Assisted Reproductive Technology (Regulation) Act, 2021 (sections 26 and 32)
Source: 1994, Government of India (Act No. 57 of 1994) - The Pre-Conception and Pre-Natal Diagnostic Techniques Act, 1994 (PCPNDT Act, as amended)
At the clinic
On Day OB-6 the faculty discusses PGT counselling with you on an anonymised case: the indication, what to say about limits, and the legal points. Ultrasound scans are watched only: no trainee holds the probe on a patient (PCPNDT Act).
The lab side
Basic picture only: biopsy at the blastocyst stage, freezing while results are awaited, and careful labelling so every result matches its embryo. You see this on the lab screen if a biopsy is scheduled; you do not handle embryos.
Common mistakes
- Offering PGT-A to every couple as an upgrade
- Starting PGT-M without the family's genetic report and counselling
- Not warning the couple that no embryo may be suitable
- Any word, note or report that reveals the sex of an embryo without a medical reason
Key points
- PGT-M, PGT-SR and PGT-A answer different questions
- PGT-A is not recommended routinely; it can be considered in RIF
- Counsel on limits, errors and the chance of no transfer
- Indian law: PGT for genetic disease; never reveal embryo sex without a medical reason
Check yourself
Answer in your head first, then tap a question to see a short answer. Full model answers are in the faculty guidebook.
1. What is the difference between PGT-M, PGT-SR and PGT-A?
PGT-M tests for a known single-gene condition, PGT-SR for a parent's structural chromosome change, PGT-A for chromosome number.
2. What does section 25 of the ART Act say about PGT?
It shall be used to screen embryos for known, pre-existing, heritable or genetic diseases only.
3. Why does ESHRE not recommend PGT-A routinely?
Trials have not shown a higher live birth per started cycle for all patients, mosaic and false results occur, and it adds cost and biopsy.
4. What must every PGT couple be told before starting?
The steps, that not every embryo can be diagnosed, the chance of no transferable embryo, error risk, and confirmation in pregnancy.
5. What does Indian law forbid around embryo sex?
Telling or choosing the sex of an embryo, except to diagnose, prevent or treat a sex-linked disease.
6. From page 53: which part of the blastocyst forms the baby and which forms the placenta?
The inner cell mass forms the baby; the outer layer (trophectoderm) forms the placenta.
Training note. Training content for registered medical practitioners. Trainees observe all patient care; they do not treat patients during the programme.
Questions on this page
Is PGT-A recommended for every IVF couple?
No. ESHRE does not recommend PGT-A for routine use.
Can PGT be used to know an embryo's sex?
No. Indian law forbids it except to diagnose, prevent or treat a sex-linked disease.
The Genesis Doctors' Textbook is teaching text for registered medical practitioners on the doctor programmes of the Genesis ART Training Academy. It is not treatment advice and gives no medicine doses; trainees observe all patient care, ultrasound scans are watched only (PCPNDT Act), and bench skills are practised under supervision. Page numbers never change.
